• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宏基因组分析揭示了不同严重程度的 SARS-CoV-2 患者中病毒物种的共存和丰度的差异。

Metagenomic analysis reveals differences in the co-occurrence and abundance of viral species in SARS-CoV-2 patients with different severity of disease.

机构信息

Departamento de Genética del Desarrollo y Fisiología Molecular, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca, Morelos, Mexico.

Centro de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.

出版信息

BMC Infect Dis. 2022 Oct 19;22(1):792. doi: 10.1186/s12879-022-07783-8.

DOI:10.1186/s12879-022-07783-8
PMID:36261802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9580447/
Abstract

BACKGROUND

SARS-CoV-2 infections have a wide spectrum of clinical manifestations whose causes are not completely understood. Some human conditions predispose to severe outcome, like old age or the presence of comorbidities, but many other facets, including coinfections with other viruses, remain poorly characterized.

METHODS

In this study, the eukaryotic fraction of the respiratory virome of 120 COVID-19 patients was characterized through whole metagenomic sequencing.

RESULTS

Genetic material from respiratory viruses was detected in 25% of all samples, whereas human viruses other than SARS-CoV-2 were found in 80% of them. Samples from hospitalized and deceased patients presented a higher prevalence of different viruses when compared to ambulatory individuals. Small circular DNA viruses from the Anneloviridae (Torque teno midi virus 8, TTV-like mini virus 19 and 26) and Cycloviridae families (Human associated cyclovirus 10), Human betaherpesvirus 6, were found to be significantly more abundant in samples from deceased and hospitalized patients compared to samples from ambulatory individuals. Similarly, Rotavirus A, Measles morbillivirus and Alphapapilomavirus 10 were significantly more prevalent in deceased patients compared to hospitalized and ambulatory individuals.

CONCLUSIONS

Results show the suitability of using metagenomics to characterize a broader peripheric virological landscape of the eukaryotic virome in SARS-CoV-2 infected patients with distinct disease outcomes. Identified prevalent viruses in hospitalized and deceased patients may prove important for the targeted exploration of coinfections that may impact prognosis.

摘要

背景

SARS-CoV-2 感染的临床表现范围广泛,其病因尚不完全清楚。一些人类状况易导致严重后果,如老年或合并症,但许多其他方面,包括与其他病毒的合并感染,仍未得到充分描述。

方法

在这项研究中,通过全宏基因组测序对 120 例 COVID-19 患者的呼吸病毒组的真核部分进行了特征描述。

结果

在所有样本中,25%的样本检测到呼吸道病毒的遗传物质,而在其中 80%的样本中发现了除 SARS-CoV-2 以外的人类病毒。与门诊患者相比,住院和死亡患者的样本中存在不同病毒的流行率更高。安尔诺病毒科(扭形病毒 8、TTV 样微小病毒 19 和 26)和环病毒科(人相关环病毒 10)的小环形 DNA 病毒、人类疱疹病毒 6 被发现明显更丰富在死亡和住院患者的样本中比门诊患者的样本。同样,轮状病毒 A、麻疹腮腺炎病毒和α乳头瘤病毒 10 在死亡患者中的流行率明显高于住院和门诊患者。

结论

结果表明,使用宏基因组学来描述具有不同疾病结局的 SARS-CoV-2 感染患者外周真核病毒组更广泛的病毒学特征是合适的。在住院和死亡患者中发现的流行病毒可能对探索可能影响预后的合并感染具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a25c/9583562/443659bbcf92/12879_2022_7783_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a25c/9583562/a0f4802e9590/12879_2022_7783_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a25c/9583562/443659bbcf92/12879_2022_7783_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a25c/9583562/a0f4802e9590/12879_2022_7783_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a25c/9583562/443659bbcf92/12879_2022_7783_Fig2_HTML.jpg

相似文献

1
Metagenomic analysis reveals differences in the co-occurrence and abundance of viral species in SARS-CoV-2 patients with different severity of disease.宏基因组分析揭示了不同严重程度的 SARS-CoV-2 患者中病毒物种的共存和丰度的差异。
BMC Infect Dis. 2022 Oct 19;22(1):792. doi: 10.1186/s12879-022-07783-8.
2
Temporal landscape of human gut RNA and DNA virome in SARS-CoV-2 infection and severity.人类肠道 RNA 和 DNA 病毒组在 SARS-CoV-2 感染及严重程度中的时变景观。
Microbiome. 2021 Apr 14;9(1):91. doi: 10.1186/s40168-021-01008-x.
3
Absence of pathogenic viruses in COVID-19 convalescent plasma.新冠康复期血浆中不存在致病性病毒。
Transfusion. 2023 Jan;63(1):23-29. doi: 10.1111/trf.17168. Epub 2022 Nov 3.
4
Genomic Characterization of SARS-CoV-2 Isolated from Patients with Distinct Disease Outcomes in Mexico.墨西哥不同疾病结局患者分离的 SARS-CoV-2 的基因组特征。
Microbiol Spectr. 2022 Feb 23;10(1):e0124921. doi: 10.1128/spectrum.01249-21. Epub 2022 Jan 12.
5
Metagenomic Sequencing To Detect Respiratory Viruses in Persons under Investigation for COVID-19.宏基因组测序在针对 COVID-19 进行调查的人群中检测呼吸道病毒。
J Clin Microbiol. 2020 Dec 17;59(1). doi: 10.1128/JCM.02142-20.
6
Viral epidemiology and SARS-CoV-2 co-infections with other respiratory viruses during the first COVID-19 wave in Paris, France.法国巴黎首次 COVID-19 浪潮期间的病毒流行病学和 SARS-CoV-2 与其他呼吸道病毒的合并感染。
Influenza Other Respir Viruses. 2021 Jul;15(4):425-428. doi: 10.1111/irv.12853. Epub 2021 Apr 4.
7
Respiratory viral co-infections among SARS-CoV-2 cases confirmed by virome capture sequencing.呼吸道病毒合并感染在通过病毒组捕获测序确认的 SARS-CoV-2 病例中。
Sci Rep. 2021 Feb 16;11(1):3934. doi: 10.1038/s41598-021-83642-x.
8
[Coinfections by SARS-CoV-2 and other respiratory viruses and their clinical outcome].[新型冠状病毒肺炎与其他呼吸道病毒的合并感染及其临床结局]
Rev Med Inst Mex Seguro Soc. 2021 Nov 1;59(6):482-489.
9
Analysis of coexisting pathogens in nasopharyngeal swabs from COVID-19.分析新冠病毒鼻咽拭子中的共感染病原体。
Front Cell Infect Microbiol. 2023 Jun 22;13:1140548. doi: 10.3389/fcimb.2023.1140548. eCollection 2023.
10
Nasopharyngeal virome analysis of COVID-19 patients during three different waves in Campania region of Italy.意大利坎帕尼亚地区 COVID-19 患者三个不同波次期间鼻咽病毒组分析。
J Med Virol. 2022 May;94(5):2275-2283. doi: 10.1002/jmv.27571. Epub 2022 Jan 15.

引用本文的文献

1
VirDetect-AI: a residual and convolutional neural network-based metagenomic tool for eukaryotic viral protein identification.VirDetect-AI:一种基于残差和卷积神经网络的宏基因组工具,用于真核病毒蛋白鉴定。
Brief Bioinform. 2024 Nov 22;26(1). doi: 10.1093/bib/bbaf001.
2
Immune Stimulation with Imiquimod to Best Face SARS-CoV-2 Infection and Prevent Long COVID.用咪喹莫特刺激免疫以最大程度地减少 SARS-CoV-2 感染并预防长新冠。
Int J Mol Sci. 2024 Jul 12;25(14):7661. doi: 10.3390/ijms25147661.
3
Metagenomic and Molecular Detection of Novel Fecal Viruses in Free-Ranging Agile Wallabies.

本文引用的文献

1
SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)与流感病毒、呼吸道合胞病毒或腺病毒的合并感染。
Lancet. 2022 Apr 16;399(10334):1463-1464. doi: 10.1016/S0140-6736(22)00383-X. Epub 2022 Mar 25.
2
Co-infection of SARS-CoV-2 and influenza viruses: A systematic review and meta-analysis.新型冠状病毒与流感病毒的合并感染:一项系统评价与荟萃分析。
J Clin Virol Plus. 2021 Sep;1(3):100036. doi: 10.1016/j.jcvp.2021.100036. Epub 2021 Aug 9.
3
Coinfection with SARS-CoV-2 and Influenza A Virus Increases Disease Severity and Impairs Neutralizing Antibody and CD4 T Cell Responses.
宏基因组学和分子检测技术在野生敏捷袋鼠粪便样本中新型肠道病毒的应用。
Ecohealth. 2023 Dec;20(4):427-440. doi: 10.1007/s10393-023-01659-2. Epub 2023 Dec 13.
SARS-CoV-2 与甲型流感病毒合并感染会加重疾病严重程度,并损害中和抗体和 CD4 T 细胞应答。
J Virol. 2022 Mar 23;96(6):e0187321. doi: 10.1128/jvi.01873-21. Epub 2022 Feb 2.
4
Genomic Characterization of SARS-CoV-2 Isolated from Patients with Distinct Disease Outcomes in Mexico.墨西哥不同疾病结局患者分离的 SARS-CoV-2 的基因组特征。
Microbiol Spectr. 2022 Feb 23;10(1):e0124921. doi: 10.1128/spectrum.01249-21. Epub 2022 Jan 12.
5
Nasopharyngeal virome analysis of COVID-19 patients during three different waves in Campania region of Italy.意大利坎帕尼亚地区 COVID-19 患者三个不同波次期间鼻咽病毒组分析。
J Med Virol. 2022 May;94(5):2275-2283. doi: 10.1002/jmv.27571. Epub 2022 Jan 15.
6
The prevalence of early- and late-onset bacterial, viral, and fungal respiratory superinfections in invasively ventilated COVID-19 patients.COVID-19 患者有创机械通气后早发和晚发细菌、病毒和真菌呼吸道合并感染的发生率。
J Med Virol. 2022 May;94(5):1920-1925. doi: 10.1002/jmv.27548. Epub 2022 Jan 4.
7
SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets.SARS-CoV-2 和甲型流感病毒在雪貂中的合并感染。
J Virol. 2022 Mar 9;96(5):e0179121. doi: 10.1128/JVI.01791-21. Epub 2021 Dec 22.
8
Severe Acute Respiratory Syndrome Coronavirus 2 and Respiratory Virus Sentinel Surveillance, California, USA, May 10, 2020-June 12, 2021.2020 年 5 月 10 日至 2021 年 6 月 12 日,美国加利福尼亚州严重急性呼吸综合征冠状病毒 2 型和呼吸道病毒哨点监测。
Emerg Infect Dis. 2022 Jan;28(1):9-19. doi: 10.3201/eid2801.211682.
9
Dysbiosis and structural disruption of the respiratory microbiota in COVID-19 patients with severe and fatal outcomes.COVID-19 患者中严重和致命结局与呼吸微生物群失调和结构破坏。
Sci Rep. 2021 Oct 29;11(1):21297. doi: 10.1038/s41598-021-00851-0.
10
Respiratory Pathogen Coinfections in SARS-CoV-2-Positive Patients in Southeastern Wisconsin: A Retrospective Analysis.呼吸道病原体合并感染在威斯康星州东南部 SARS-CoV-2 阳性患者中的回顾性分析。
Microbiol Spectr. 2021 Oct 31;9(2):e0083121. doi: 10.1128/Spectrum.00831-21. Epub 2021 Oct 20.